| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 1, no: 10 | 
| NetGPI | no | yes: 0, no: 11 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005840 | ribosome | 5 | 12 | 
| GO:0032991 | protein-containing complex | 1 | 11 | 
| GO:0043226 | organelle | 2 | 12 | 
| GO:0043228 | non-membrane-bounded organelle | 3 | 12 | 
| GO:0043229 | intracellular organelle | 3 | 12 | 
| GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 12 | 
| GO:0110165 | cellular anatomical entity | 1 | 12 | 
| GO:1990904 | ribonucleoprotein complex | 2 | 11 | 
Related structures:
AlphaFold database: E9B284
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006412 | translation | 4 | 12 | 
| GO:0006518 | peptide metabolic process | 4 | 12 | 
| GO:0006807 | nitrogen compound metabolic process | 2 | 12 | 
| GO:0008152 | metabolic process | 1 | 12 | 
| GO:0009058 | biosynthetic process | 2 | 12 | 
| GO:0009059 | macromolecule biosynthetic process | 4 | 12 | 
| GO:0009987 | cellular process | 1 | 12 | 
| GO:0019538 | protein metabolic process | 3 | 12 | 
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 | 
| GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 12 | 
| GO:0043043 | peptide biosynthetic process | 5 | 12 | 
| GO:0043170 | macromolecule metabolic process | 3 | 12 | 
| GO:0043603 | amide metabolic process | 3 | 12 | 
| GO:0043604 | amide biosynthetic process | 4 | 12 | 
| GO:0044237 | cellular metabolic process | 2 | 12 | 
| GO:0044238 | primary metabolic process | 2 | 12 | 
| GO:0044249 | cellular biosynthetic process | 3 | 12 | 
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 | 
| GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 12 | 
| GO:0071704 | organic substance metabolic process | 2 | 12 | 
| GO:1901564 | organonitrogen compound metabolic process | 3 | 12 | 
| GO:1901566 | organonitrogen compound biosynthetic process | 4 | 12 | 
| GO:1901576 | organic substance biosynthetic process | 3 | 12 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003735 | structural constituent of ribosome | 2 | 12 | 
| GO:0005198 | structural molecule activity | 1 | 12 | 
| GO:0003676 | nucleic acid binding | 3 | 1 | 
| GO:0003723 | RNA binding | 4 | 1 | 
| GO:0003729 | mRNA binding | 5 | 1 | 
| GO:0005488 | binding | 1 | 1 | 
| GO:0097159 | organic cyclic compound binding | 2 | 1 | 
| GO:1901363 | heterocyclic compound binding | 2 | 1 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.672 | 
| CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.604 | 
| CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.242 | 
| CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.726 | 
| CLV_Separin_Metazoa | 77 | 81 | PF03568 | 0.708 | 
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.701 | 
| DEG_SIAH_1 | 114 | 122 | PF03145 | 0.606 | 
| DOC_MAPK_gen_1 | 161 | 171 | PF00069 | 0.328 | 
| DOC_MAPK_gen_1 | 196 | 204 | PF00069 | 0.449 | 
| DOC_MAPK_gen_1 | 35 | 45 | PF00069 | 0.711 | 
| DOC_MAPK_MEF2A_6 | 141 | 150 | PF00069 | 0.413 | 
| DOC_PP2B_LxvP_1 | 43 | 46 | PF13499 | 0.661 | 
| DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.634 | 
| DOC_USP7_UBL2_3 | 137 | 141 | PF12436 | 0.595 | 
| DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.719 | 
| LIG_14-3-3_CanoR_1 | 14 | 21 | PF00244 | 0.655 | 
| LIG_Actin_WH2_2 | 182 | 200 | PF00022 | 0.413 | 
| LIG_FHA_1 | 145 | 151 | PF00498 | 0.354 | 
| LIG_FHA_1 | 15 | 21 | PF00498 | 0.637 | 
| LIG_FHA_2 | 140 | 146 | PF00498 | 0.643 | 
| LIG_FHA_2 | 174 | 180 | PF00498 | 0.396 | 
| LIG_LIR_Gen_1 | 57 | 67 | PF02991 | 0.544 | 
| LIG_SH2_GRB2like | 59 | 62 | PF00017 | 0.510 | 
| LIG_SH2_SRC | 94 | 97 | PF00017 | 0.619 | 
| LIG_SH2_STAP1 | 94 | 98 | PF00017 | 0.598 | 
| LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.529 | 
| LIG_SH3_3 | 115 | 121 | PF00018 | 0.637 | 
| LIG_SUMO_SIM_par_1 | 88 | 93 | PF11976 | 0.440 | 
| LIG_SxIP_EBH_1 | 29 | 38 | PF03271 | 0.513 | 
| LIG_TRAF2_1 | 170 | 173 | PF00917 | 0.364 | 
| LIG_WRC_WIRS_1 | 67 | 72 | PF05994 | 0.500 | 
| MOD_CK2_1 | 167 | 173 | PF00069 | 0.410 | 
| MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.625 | 
| MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.622 | 
| MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.611 | 
| MOD_NEK2_1 | 144 | 149 | PF00069 | 0.385 | 
| MOD_NEK2_1 | 20 | 25 | PF00069 | 0.668 | 
| MOD_NEK2_1 | 99 | 104 | PF00069 | 0.634 | 
| MOD_PKB_1 | 12 | 20 | PF00069 | 0.634 | 
| MOD_Plk_1 | 139 | 145 | PF00069 | 0.602 | 
| MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.717 | 
| MOD_SUMO_rev_2 | 170 | 177 | PF00179 | 0.397 | 
| TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.529 | 
| TRG_ER_diArg_1 | 1 | 4 | PF00400 | 0.695 | 
| TRG_ER_diArg_1 | 12 | 15 | PF00400 | 0.693 | 
| TRG_NES_CRM1_1 | 162 | 173 | PF08389 | 0.291 | 
| TRG_Pf-PMV_PEXEL_1 | 4 | 9 | PF00026 | 0.684 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1I2G0 | Leptomonas seymouri | 62% | 100% | 
| A0A0S4JKH3 | Bodo saltans | 35% | 88% | 
| A0A1X0NIA7 | Trypanosomatidae | 48% | 100% | 
| A0A3Q8IFU2 | Leishmania donovani | 92% | 100% | 
| A0A422NF54 | Trypanosoma rangeli | 42% | 100% | 
| A4HJS3 | Leishmania braziliensis | 75% | 100% | 
| A4I789 | Leishmania infantum | 91% | 100% | 
| C9ZMG8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 99% | 
| Q4Q5X4 | Leishmania major | 90% | 100% | 
| V5BGN2 | Trypanosoma cruzi | 43% | 72% |